# Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

> **NCT07041320** · — · RECRUITING · sponsor: **Anhui Chest Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Lung Cancer (NSCLC)
- Elderly (People Aged 65 or More)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07041320
- **Lead sponsor:** Anhui Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07041320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07041320, "Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07041320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*